Shire selling Baxalta site in Austria once earmarked to make hemophilia drug
Shire has confirmed it is selling a former Baxalta manufacturing site in Austria once earmarked for a €138m ($145m) expansion and modernisation.
Archives for January 6, 2017
US biosimilars will continue to blossom under Trump, say experts
Trump’s presidency could favour US biosimilars in 2017, but the sector will continue to be hampered by a lack of interchangeability guidance and ongoing litigation, say experts.
OTCQB: PMCB
Cell-in-a-Box: PharmaCyte seeks FDA advice for inoperable cancer trial
PharmaCyte has announced a pre-application meeting with the US FDA, to advise on their investigational new drug (IND) filing for a clinical trial its live cell encapsulation therapy.